Last $4.78 USD
Change Today -0.25 / -4.97%
Volume 1.5M
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - PROGENICS PHARMACEUTICALS (PGNX)

2013 revenues at Progenics Pharmaceuticals, Inc. totaled $7.9M USD, while annual losses equaled $0.76 per share.

Quarterly Earnings & Estimates - PROGENICS PHARMACEUTICALS (PGNX)

Actuals vs. Estimates for PROGENICS PHARMACEUTICALS PGNX

Progenics Pharmaceuticals, Inc.'s Quarterly Earnings

Progenics Pharmaceuticals, Inc. reported 1st quarter 2014 losses of $0.15 per share on 05/11/2014.

Annual Earnings & Estimates - PROGENICS PHARMACEUTICALS (PGNX)

Actuals vs. Estimates for PROGENICS PHARMACEUTICALS PGNX

Progenics Pharmaceuticals, Inc.'s Annual Earnings

Progenics Pharmaceuticals, Inc. reported annual 2013 losses of $0.76 per share on 03/15/2014.

Quarterly Revenues - PROGENICS PHARMACEUTICALS (PGNX)

Actuals vs. Estimates for PROGENICS PHARMACEUTICALS PGNX

Progenics Pharmaceuticals, Inc.'s Quarterly Revenues

Progenics Pharmaceuticals, Inc. had 1st quarter 2014 revenues of $1.8M USD. This missed the $3.4M USD consensus estimate of the 2 analysts following the company. This was -18.5% below the prior year's 1st quarter results.

Annual Revenues - PROGENICS PHARMACEUTICALS (PGNX)

Actuals vs. Estimates for PROGENICS PHARMACEUTICALS PGNX

Progenics Pharmaceuticals, Inc.'s Annual Revenues

Progenics Pharmaceuticals, Inc. had revenues for the full year 2013 of $7.9M USD. This was -44.0% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $4.78 USD -0.25

PGNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dynavax Technologies Corp $1.48 USD -0.03
Genocea Biosciences Inc $17.41 USD +0.61
Peregrine Pharmaceuticals Inc $1.51 USD -0.04
Rigel Pharmaceuticals Inc $3.27 USD -0.14
ZIOPHARM Oncology Inc $3.13 USD -0.13
View Industry Companies
 

Industry Analysis

PGNX

Industry Average

Valuation PGNX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 43.2x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 34.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.